Artisan Partners’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-903,292
Closed -$39.4M 371
2025
Q3
$39.4M Buy
903,292
+21,338
+2% +$863K 0.06% 240
2025
Q2
$25M Sell
881,954
-46,273
-5% -$1.38M 0.04% 281
2025
Q1
$27.4M Sell
928,227
-87,024
-9% -$2.71M 0.04% 265
2024
Q4
$29.5M Sell
1,015,251
-314,028
-24% -$13.1M 0.04% 279
2024
Q3
$61.1M Sell
1,329,279
-572,786
-30% -$24.9M 0.09% 199
2024
Q2
$77.7M Sell
1,902,065
-424,436
-18% -$12.2M 0.12% 169
2024
Q1
$59.4M Buy
2,326,501
+223,479
+11% +$3.5M 0.09% 207
2023
Q4
$19M Sell
2,103,022
-50,876
-2% -$340K 0.03% 268
2023
Q3
$13.7M Hold
2,153,898
0.02% 263
2023
Q2
$23.9M Buy
2,153,898
+248,577
+13% +$3.12M 0.04% 242
2023
Q1
$29.2M Buy
1,905,321
+604,345
+46% +$13.3M 0.05% 242
2022
Q4
$28.9M Buy
1,300,976
+910,048
+233% +$13.6M 0.05% 240
2022
Q3
$6.38M Sell
390,928
-2,413
-0.6% -$46.2K 0.01% 292
2022
Q2
$5.71M Buy
+393,341
New +$5.85M 0.01% 299

Other funds holding RNAM

Artisan Partners's RNAM Position: Q4 2025 in Review

Artisan Partners sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 903,292 shares — an estimated $39.4M sold.

Artisan Partners first reported a position in RNAM in Q2 2022 and held it in 14 quarters. The position peaked at $77.7M in Q2 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Artisan Partners reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Artisan Partners sold 903,292 Avidity Biosciences shares in Q4 2025, an estimated $39.4M.
  • Artisan Partners first reported a position in Avidity Biosciences in Q2 2022 and held it in 14 quarters.
  • Artisan Partners's Avidity Biosciences position peaked at $77.7M in Q2 2024.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Artisan Partners's 13F filing for Q4 2025, filed 17 Feb 2026.